Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges

被引：11

作者：

Blumer, Ian ^{[1
,2
]}

Clement, Maureen ^{[3
]}

机构：

[1] Charles H Best Diabet Ctr, Ajax, ON, Canada

[2] Univ Toronto, Dept Med, Toronto, ON, Canada

[3] Univ British Columbia, Diabet Educ Ctr, Vernon, BC, Canada

来源：

CLINICAL THERAPEUTICS | 2017年 / 39卷 / 08期

关键词：

basal insulin; hypoglycemia; management; type; 2; diabetes; TO-TARGET TRIAL; PATIENT-REPORTED OUTCOMES; GLARGINE; 100; UNITS/ML; GLYCEMIC CONTROL; COGNITIVE FUNCTION; GLUCOSE CONTROL; NPH INSULIN; PEOPLE; DEGLUDEC; RISK;

D O I：

10.1016/j.clinthera.2016.09.020

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia can affect an individual's quality of life, and fear of hypoglycemia can lead to underinsulinization. This article explores the prevalence and consequences of hypoglycemia in people with type 2 diabetes with a focus on those who use basal insulins, offering strategies for prevention and management. It also discusses the benefits and challenges associated with new basal insulins, and their potential role in reducing hypoglycemia risk. (C) 2017 Elsevier HS Journals, Inc. All rights reserved.

引用

页码：S1 / S11

页数：11

共 50 条

[41] Association between hypoglycemia and dementia in patients with type 2 diabetes
Sheen, Yi-Jing
Sheu, Wayne H. H.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 116 : 279 - 287
[42] Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia
Zivkovic, Teodora M. Beljic
Dindic, Boris J.
Toljic, Dusica Z. Suluburic
Vulovic, Koviljka T. Milenkovic
Udovicic, Dragana L.
Zdravkovic, Dragan Z.
DIABETES THERAPY, 2019, 10 (01) : 71 - 80
[43] Efficacy and safety among second-generation and other basal insulins in adult patients with type 1 diabetes: a systematic review and network meta-analysis
Martin
Zhou, Yi
Takagi, Tatsuya
Tian, Yu-Shi
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (10) : 2091 - 2101
[44] Hypoglycemia, diabetes therapies and driving categories in type 2 diabetes
Feher, Michael D.
Langerman, Haya
Evans, Marc
CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (06) : 1005 - 1012
[45] Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysis
Luo, Yingying
Xia, Jun
Zhao, Zhan
Chang, Yaping
Bee, Yong Mong
Nguyen, Khue Thy
Lim, Soo
Yabe, Daisuke
McGill, Margaret
Kong, Alice Pik Shan
Chan, Siew Pheng
Deodat, Marisa
Deerochanawong, Chaicharn
Suastika, Ketut
Xu, Chenchen
Chen, Liming
Chen, Wei
Li, Xiaoying
Zhao, Weigang
Yao, Xiaomei
Ji, Linong
JOURNAL OF DIABETES, 2023, 15 (05) : 419 - 435
[46] Association of Depressive Symptoms and Diabetes Distress With Severe Hypoglycemia in Adults With Type 2 Diabetes
Al Sayah, Fatima
Yeung, Roseanne O.
Johnson, Jeffrey A.
CANADIAN JOURNAL OF DIABETES, 2019, 43 (05) : 316 - 321
[47] Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003-2018
Brunetti, Vanessa C.
Yu, Oriana H. Y.
Platt, Robert W.
Filion, Kristian B.
DIABETIC MEDICINE, 2021, 38 (08)
[48] Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins
Arutchelvam, V.
Heise, T.
Dellweg, S.
Elbroend, B.
Minns, I.
Home, P. D.
DIABETIC MEDICINE, 2009, 26 (10) : 1027 - 1032
[49] Effects of basal insulin application on serum visfatin and adiponectin levels in type 2 diabetes
Wang, Wei-Dong
Xing, Lin
Teng, Jun-Ru
Li, Shuo
Mi, Na
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2219 - 2224
[50] Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes
Swinnen, S. G. H. A.
DeVries, J. H.
DIABETOLOGIA, 2009, 52 (11) : 2324 - 2327

← 1 2 3 4 5 →